These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24807498)

  • 21. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis/bladder pain syndrome refractory to conventional treatment - A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Kuo HC; Jiang YH; Tsai YC; Kuo YC
    Neurourol Urodyn; 2016 Jun; 35(5):609-14. PubMed ID: 25914337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interstitial cystitis is bladder pain syndrome with Hunner's lesion.
    Fall M; Logadottir Y; Peeker R
    Int J Urol; 2014 Apr; 21 Suppl 1():79-82. PubMed ID: 24807507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistent therapeutic effect of repeated injections of onabotulinum toxin a in refractory bladder pain syndrome/interstitial cystitis.
    Pinto R; Lopes T; Silva J; Silva C; Dinis P; Cruz F
    J Urol; 2013 Feb; 189(2):548-53. PubMed ID: 23253961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of bladder instillation in the treatment of bladder pain syndrome: Is intravesical treatment an effective option for patients with bladder pain as well as LUTS?
    Digesu GA; Tailor V; Bhide AA; Khullar V
    Int Urogynecol J; 2020 Jul; 31(7):1387-1392. PubMed ID: 32358624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravesical injection of botulinum toxin A for treatment of interstitial cystitis/bladder pain syndrome: 10 years of experience at a single center in China.
    Gao Y; Liao L
    Int Urogynecol J; 2015 Jul; 26(7):1021-6. PubMed ID: 25690160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential Effect of Liposomes and Liposome-Encapsulated Botulinum Toxin and Tacrolimus in the Treatment of Bladder Dysfunction.
    Janicki JJ; Chancellor MB; Kaufman J; Gruber MA; Chancellor DD
    Toxins (Basel); 2016 Mar; 8(3):. PubMed ID: 26999210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A for the treatment of lower urinary tract disorders.
    Yokoyama T; Chancellor MB; Oguma K; Yamamoto Y; Suzuki T; Kumon H; Nagai A
    Int J Urol; 2012 Mar; 19(3):202-15. PubMed ID: 22220916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial comment from Dr. Hanno to hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
    Hanno P
    Int J Urol; 2014 Apr; 21 Suppl 1():48. PubMed ID: 24807496
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial comment from Dr. Nordling to hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
    Nordling J
    Int J Urol; 2014 Apr; 21 Suppl 1():48. PubMed ID: 24807495
    [No Abstract]   [Full Text] [Related]  

  • 31. Novel Treatment of Chronic Bladder Pain Syndrome and Other Pelvic Pain Disorders by OnabotulinumtoxinA Injection.
    Jhang JF; Kuo HC
    Toxins (Basel); 2015 Jun; 7(6):2232-50. PubMed ID: 26094697
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Words of wisdom. Re: Intrathecal administration of botulinum toxin type a improves urinary bladder function and reduces pain in rats with cystitis.
    Apostolidis A
    Eur Urol; 2015 Apr; 67(4):816. PubMed ID: 25765213
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial Comment: Intravesical injections of platelet-rich plasma is effective and safe in treatment of interstitial cystitis refractory to conventional treatment-A prospective clinical trial.
    Riccetto CLZ
    Int Braz J Urol; 2021; 47(2):456-457. PubMed ID: 33284551
    [No Abstract]   [Full Text] [Related]  

  • 34. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current and potential urological applications of botulinum toxin A.
    Jiang YH; Liao CH; Kuo HC
    Nat Rev Urol; 2015 Sep; 12(9):519-33. PubMed ID: 26260879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A.
    Pinto R; Lopes T; Costa D; Barros S; Silva J; Silva C; Cruz C; Dinis P; Cruz F
    Urology; 2014 May; 83(5):1030-4. PubMed ID: 24767520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Editorial Comment from Dr Hanno to Intravesical tacrolimus in treatment of intractable bladder pain syndrome/interstitial cystitis-a pilot study.
    Hanno P
    Int J Urol; 2019 Jun; 26 Suppl 1():72. PubMed ID: 31144763
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of Botulinum Toxin in Urologic Diseases.
    Chermansky CJ; Chancellor MB
    Urology; 2016 May; 91():21-32. PubMed ID: 26777748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preliminary results of suburothelial injection of botulinum a toxin in the treatment of chronic interstitial cystitis.
    Kuo HC
    Urol Int; 2005; 75(2):170-4. PubMed ID: 16123573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.